Palladium octaethylporphyrin

Palladium octaethylporphyrin is a biomedical product utilized in the drug development of various diseases. With its unique chemical properties, it is employed as a catalyst for numerous biomedicine-related reactions. It is particularly effective in promoting drug delivery systems and molecular imaging techniques, enhancing the efficacy of anticancer drugs and helping researchers gain new insights into bioactive compounds.

Palladium, [2,3,7,8,12,13,17,18-octaethyl-21H,23H-porphinato(2-)-κN21,κN22,κN23,κN24]-, (SP-4-1)-; (SP-4-1)-[2,3,7,8,12,13,17,18-Octaethyl-21H,23H-porphinato(2-)-κN21,κN22,κN23,κN24]palladium; 21H,23H-Porphine, 2,3,7,8,12,13,17,18-octaethyl-, palladium complex; Palladium, [2,3,7,8,12,13,17,18-octaethyl-21H,23H-porphinato(2-)-N21,N22,N23,N24]-, (SP-4-1)-; Palladium, [2,3,7,8,12,13,17,18-octaethylporphinato(2-)]-; (2,3,7,8,12,13,17,18-Octaethylporphyrinato)palladium; (Octaethylporphyrinato)palladium; 2,3,7,8,12,13,17,18-Octaethyl-21H,23H-porphine palladium(II); Octaethylporphinatopalladium; Palladium(2+) octaethylporphyrin; Palladium(II) octaethylporphyrin; Palladium-octaethylporphine; PdOEP

palladium(II);2,3,7,8,12,13,17,18-octaethylporphyrin-21,23-diide

C=1C=2C(=C(C3=CC4=C(C(=C5C=C6C(=C(C=7C=C8C(=C(C1[N-]8[Pd+2]([N]23)([N]76)[N-]45)CC)CC)CC)CC)CC)CC)CC)CC

InChI=1S/C36H44N4.Pd/c1-9-21-22(10-2)30-18-32-25(13-5)26(14-6)34(39-32)20-36-28(16-8)27(15-7)35(40-36)19-33-24(12-4)23(11-3)31(38-33)17-29(21)37-30;/h17-20H,9-16H2,1-8H3;/q-2;+2/b29-17-,30-18-,31-17?,32-18?,33-19-,34-20-,35-19?,36-20?;

FVPOYVGWFFRIHG-RNUBSZNLSA-N

Not applicable

≥95%

Purple powder or crystals